1. Hong Kong Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Kelfred Holdings Limited

Kelfred Holdings Limited

1134.HK
Kelfred Holdings LimitedHK flagHong Kong Stock Exchange
0.34
HKD
+0.00
- -
167.50MMarket Cap
Kelfred Holdings Limited
1134.HK
(Hong Kong Stock Exchange)

Recent

price

0.34

P/E

ratio

- -

div

yld

- -

ROIC.AI

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.64
0.73
0.84
0.95
0.71
0.87
0.93
0.79
0.91
1
Revenue per Share
0.09
0.06
0.06
0.02
-0.03
- -
0.02
- -
-0.04
-0.03
Basic EPS, GAAP
0.04
0.02
0.02
- -
0.03
-0.05
0.03
-0.04
0.03
0.05
Free Cash Flow per Basic Share
0.02
0.01
- -
- -
0.02
- -
- -
- -
- -
- -
Dividend per Share
0.09
0.12
0.05
0.09
0.01
0.04
0.05
0.05
0.01
-0.02
Book Value per Share
0.2
0.3
0.19
0.48
0.37
0.37
0.37
0.37
0.31
0.3
Tangible Book Value per Share
500
500
500
433
500
500
500
500
500
500
Basic Weighted Avg Shares
318
363
421
413
354
435
465
393
454
500
Sales/Revenue/Turnover
15.7
11.89
8.65
2.9
-0.71
0.37
1.51
-3.35
-5.26
-2.14
Operating Margin (%)
4
8
10
12
13
14
10
10
12
11
Depreciation Expense
44
32
30
8
-13
-2
9
1
-22
-15
Net Income, GAAP
17.29
19.61
19.13
33.75
- -
- -
14.02
36.27
- -
- -
Effective Tax Rate (%)
13.9
8.91
7.22
2.03
-3.78
-0.49
1.97
0.35
-4.77
-3.02
Profit Margin (%)
65
100
56
167
146
152
158
145
122
118
Working Capital
1
1
- -
4
3
1
1
12
9
5
LT Debt
102
148
97
208
185
186
187
183
156
148
Total Equity
- -
21.83
18.25
4.18
- -
- -
3.16
-4.32
- -
- -
Return on Invested Capital (%)
- -
40.74
39.75
13.42
- -
- -
39.47
7.02
- -
- -
Return on Capital (%)
- -
63.56
71.01
25.1
-59.94
-18.75
42.01
5.26
-136.53
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-4.16%
-5.09%
Free Cash Flow
- -
-142%
106.93%
Net Income, GAAP
- -
-477.33%
-30.11%
Sales/Revenue/Turnover
- -
7.98%
10.29%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
393
2024
- -
- -
- -
- -
454
2025
- -
- -
- -
- -
500

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
-0.04
2025
- -
- -
- -
- -
-0.03

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Nyxoah S.A. (NYXH)
KORU Medical Systems, Inc. (KRMD)
Autek China Inc. (300595.SZ)
Elos Medtech AB (publ) (ELOS-B.ST)
Kawamoto Corporation (3604.T)
Opsens Inc. (OPSSF)
Business
Kelfred Holdings Limited (1134.HK) is an investment holding company principally engaged in the design, manufacture and sale of eyewear products, including a wide range of spectacle frames and sunglasses primarily through original design manufacturing (ODM), original equipment manufacturing (OEM) and original brand manufacturing (OBM) business models; it offers integrated and customized services encompassing product design and development, raw materials procurement, production, quality control, packaging and delivery; and it also engages in property holding activities. The company operates two major production bases in Shenzhen and Jiangxi in the People's Republic of China (PRC), serving international eyewear retailers, trading companies and licensed brand owners primarily in Europe, as well as Italy, the United Kingdom, the Netherlands, Hong Kong, France, Japan, Australia, the United States and other international markets. Founded in 1986 and headquartered at Workshops 1605-1606, 16/F, Block B, New Trade Plaza, 6 On Ping Street, Sha Tin, New Territories, Hong Kong, Kelfred Holdings Limited is a subsidiary of Conquer Holding Limited. In recent developments, the company terminated a potential disposal and offer process following unsuccessful discussions with a prospective purchaser; it confirmed that a mandatory general offer for its shares will not proceed; and trading in its shares was temporarily halted on the Hong Kong Stock Exchange on December 1, 2025, pending an announcement on inside information.